Abstract:Abstract Background Lung cancer is the most common malignant tumor, and it has a high mortality rate. However, the study of miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer (NSCLC) is insufficient. Therefore, this study explored the differential expression of mRNA and miRNA in the plasma of NSCLC patients. Methods The Gene Expression Omnibus (GEO) database was used to download microarray datasets, and the differentially expressed miRNAs (DEMs) were analyzed. We predicted transcription factors and target genes of the DEMs by using FunRich software and the TargetScanHuman database, respectively. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used for GO annotation and KEGG enrichment analysis of downstream target genes. We constructed protein-protein interaction (PPI) and DEM-hub gene networks using the STRING database and Cytoscape software. The GSE20189 dataset was used to screen out the key hub gene. Using The Cancer Genome Atlas (TCGA) and UALCAN databases to analyze the expression and prognosis of the key hub gene and DEMs. Then, GSE17681 and GSE137140 datasets were used to validate DEMs expression. Finally, the receiver operating characteristic (ROC) curve was used to verify the ability of the DEMs to distinguish lung cancer patients from healthy patients. Results Four upregulated candidate DEMs (hsa-miR199a-5p, hsa-miR-186-5p, hsa-miR-328-3p, and hsa-let-7d-3p) were screened from 3 databases, and 6 upstream transcription factors and 2253 downstream target genes were predicted. These genes were mainly enriched in cancer pathways and PI3k-Akt pathways. Among the top 30 hub genes, the expression of KLHL3 was consistent with the GSE20189 dataset. Except for let-7d-3p, the expression of other DEMs and KLHL3 in tissues were consistent with those in plasma. LUSC patients with high let-7d-3p expression had poor overall survival rates (OS). External validation demonstrated that the expression of hsa-miR-199a-5p and hsa-miR-186-5p in peripheral blood of NSCLC patients was higher than the healthy controls. The ROC curve confirmed that the DEMs could better distinguish lung cancer patients from healthy people. Conclusion The results showed that miR-199a-5p and miR-186-5p may be noninvasive diagnostic biomarkers for NSCLC patients. MiR-199a-5p-KLHL3 may be involved in the occurrence and development of NSCLC.

Bioinformatics Analysis Of Differentially Expressed Mirnas In Non-Small Cell Lung Cancer

Analysis of Microarray Data on Gene Expression and Methylation to Identify Long Non-coding RNAs in Non-small Cell Lung Cancer

Bioinformatics prediction of differential miRNAs in non-small cell lung cancer

Deregulated Expression of Mir-21, Mir-143 and Mir-181A in Non Small Cell Lung Cancer is Related to Clinicopathologic Characteristics or Patient Prognosis

Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer

Analysis of Genetic Variants and the Cerna Network of Mir-9 in Non-Small Cell Lung Cancer

Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer

Bioinformatics Analyses of the Differences Between Lung Adenocarcinoma and Squamous Cell Carcinoma Using the Cancer Genome Atlas Expression Data.

Differentially Expressed Mirnas in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.

Integrated Bioinformatics Analysis of Microarray Data from Non-Small Cell Lung Cancer.

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

Integrative Analysis of Mrna and Mirna Expression Profiles Reveals Seven Potential Diagnostic Biomarkers for Non‑small Cell Lung Cancer

Analysis of Microrna (mirna) Expression Profiles Reveals 11 Key Biomarkers Associated with Non-Small Cell Lung Cancer

Individualized Analysis Of Differentially Expressed Mirnas With Application To The Identification Of Mirnas Deregulated Commonly In Lung Cancer Tissues

Microarray Profiling of Differentially Expressed Lncrnas and Mrnas in Lung Adenocarcinomas and Bioinformatics Analysis

Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer

Detection of long-chain non-encoding RNA differential expression in non-small cell lung cancer by microarray analysis and preliminary verification.

Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer

Transcriptome Analysis of Lncrna-Mrna Interactions in the Non-Small Cell Lung Cancer

Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer

Identification Of Mir-133a-3p-Expression Signature And Probable Mechanism In Lung Squamous Cell Carcinoma: Insights From Integrated Analysis